• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

BSE SENSEX Next 30
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
1189
N.A
0
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
22.5
0
EPS(TTM)
Face Value()
Div & Yield %
0
100
1.23
 

sriven multi tech ltd
Abbott India Q3 PAT jumps 4% YoY to Rs 376 cr
Feb 12,2026

Profit before tax (PBT) stood at Rs 508.98 crore in Q3 FY26, up 4.38% year on year (YoY).

Total expenses increased 7.20% to Rs 1,284.82 crore in Q3 FY26 as against Rs 1,198.44 crore posted in same quarter last year. The cost of materials consumed stood at Rs 147.31 crore (up 26.88% YoY), employee benefit expense was at Rs 196.07 crore (up 45.58% YoY) and finance cost was at Rs 5.48 crore (up 142.47% YoY) during the period under review.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

Shares of Abbott India fell 1.06% to currently trade at Rs 26,609.95 on the BSE.